Clinical trialNARecruiting
Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization
[68Ga]Ga-HBED-CC-PEG6-Exendin-4 PET/CT Imaging in the Diagnosis of Insulinoma
- Outcome
- Ongoing
- Phase
- NA
- Status
- Recruiting
- Study type
- Interventional
- Start
- 1 October 2026
- Expected end
- 30 September 2027
- Enrollment
- 20 participants
- Sites
- 1
- Primary outcomes
- Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization; Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization; Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization; Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization; Diagnostic performance comparison between two GLP-1R PET tracers for insulinoma localization
- Sponsor
- Other
- Results posted
- No
- Last update
- 9 September 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try